Nader Rifai, PhD, DABCC, FACB
Telephone: (617) 355-7173
Fax: (617) 355-6081
E-mail: nader.rifai@childrens.harvard.edu

Children's Hospital

Anders Berg, MD, PhD

Novel clinical assays that address the problems of diabetes

Carlo Brugnara, MD

Sickle cell disesase, regulation of cell volume and transport of ions across the cell membrane

Gary Horowitz, MD

Immunoglobulins, Paraproteins, Diagnostic errors

Mark Kellogg, PhD, DABCC

Clinical utilization of mass spectrometry, nutritional modulation of performance, biomarkers of cognitive function

Shu-Ling Liang, PhD, DABCC, FACB

General chemistry, viral hepatitis, blood gas, celiac disease, method evaluation

Barbarajean Magnani, MD

Thyroid function, Toxicology

Nader Rifai, PhD, DABCC

Inflammation, C-reactive protein, Cardiovascular disease, biomarker validation

David Sacks, M.B., Ch.B., F.A.C.P.

The role of calmodulin in signal transduction pathways

Marion Snyder, PhD, DABCC

LC-MS/MS methods for small molecule and proteomics applications; Integration of drug pharmaco-kinetics, -dynamics and -genetics to improve drug treatment strategies and monitoring; Applications of laser-based spectroscopy techniques to in-vitro and in-vivo clinical diagnostics applications

Robert Zee, MD

Genetic predisposition to disease

Level(s) of training:
Number of position available per year:
Duration of program:
Approximate annual salary or stipend:
Source of funding:
Current number of trainees:
Number of past graduates
Positions accepted by graduates

Postdoctoral
1-2
2-3 years
$50,400 (2010)
Departmental
3
6
5 academic medical centers, 1 federal government agency

Prerequisites:

MD or PhD in physical or biological sciences.  Preference given to those individuals with previous experience in laboratory medicine.

Satisfactory completion of a minimum of 30 semester hours in undergraduate and/or graduate level chemistry or biochemistry courses prior to admission to the program.

Procedures:

Submit letter of interest, curriculum vitae, copies of undergraduate and graduate transcripts, selected publications for initial consideration. 

• Transcripts received from academic institutions outside the U.S. or Canada will require evaluation by a credentials evaluation service. See the American Board of Clinical Chemistry website for more information.  

Selected applicants will be invited to an interview that includes a seminar presentation and to submit 3 letters of reference.

Program Description:

The program mission is to train individuals with a PhD in analytical chemistry, biochemistry or related field or a MD with interests in clinical biochemistry for a career in academic clinical chemistry that includes service, teaching and research.  The minimum period of the fellowship is two years; however three years is more common.

Upon completing the fellowship, individuals will be proficient in the clinical utilization and interpretation of laboratory tests, be knowledgeable in the latest research applications of clinical biochemistry and have experience in education and management related to laboratory medicine.. It is the goal of the program that each trainee will rotate through all sections of the laboratory at either Children's Hospital, Boston or the adjacent Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center, attend weekly clinical pathology lectures, seminars, participate in endocrine and toxicology rounds and attend didactic sessions with faculty. Trainees will participate in teaching medical technologists, medical students and hospital staff. They will be
expected to conduct a research project and present data at national meetings. The experience will provide the opportunity to gain bench experience in the laboratory and provide consultationto laboratory technical staff, nurses, residents and hospital medical staff.